156 related articles for article (PubMed ID: 32440821)
21. Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer.
Alwadi D; Felty Q; Yoo C; Roy D; Deoraj A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834602
[TBL] [Abstract][Full Text] [Related]
22. NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors.
Phi JH; Sun CH; Lee SH; Lee S; Park I; Choi SA; Park SH; Lee JY; Wang KC; Kim SK; Yun H; Park CK
BMC Cancer; 2019 Aug; 19(1):848. PubMed ID: 31462227
[TBL] [Abstract][Full Text] [Related]
23. Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis.
Guo Y; Huang P; Ning W; Zhang H; Yu C
J Mol Neurosci; 2020 Nov; 70(11):1702-1712. PubMed ID: 32535713
[TBL] [Abstract][Full Text] [Related]
24. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
25. Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.
Shen Y; Dong S; Liu J; Zhang L; Zhang J; Zhou H; Dong W
Biomed Res Int; 2020; 2020():9710421. PubMed ID: 32337286
[TBL] [Abstract][Full Text] [Related]
26. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
27. Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics.
Dong C; Tian X; He F; Zhang J; Cui X; He Q; Si P; Shen Y
J Ovarian Res; 2021 Jul; 14(1):92. PubMed ID: 34253236
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways.
Fei H; Chen S; Xu C
J Ovarian Res; 2020 Jul; 13(1):82. PubMed ID: 32693821
[TBL] [Abstract][Full Text] [Related]
29. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
Zhang X; Yang L; Chen W; Kong M
Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
[TBL] [Abstract][Full Text] [Related]
30. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
31. Bioinformatics analysis identified hub genes in prostate cancer tumorigenesis and metastasis.
Gu P; Yang D; Zhu J; Zhang M; He X
Math Biosci Eng; 2021 Apr; 18(4):3180-3196. PubMed ID: 34198380
[TBL] [Abstract][Full Text] [Related]
32. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
33. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis.
Torchia J; Picard D; Lafay-Cousin L; Hawkins CE; Kim SK; Letourneau L; Ra YS; Ho KC; Chan TS; Sin-Chan P; Dunham CP; Yip S; Ng HK; Lu JQ; Albrecht S; Pimentel J; Chan JA; Somers GR; Zielenska M; Faria CC; Roque L; Baskin B; Birks D; Foreman N; Strother D; Klekner A; Garami M; Hauser P; Hortobágyi T; Bognár L; Wilson B; Hukin J; Carret AS; Van Meter TE; Nakamura H; Toledano H; Fried I; Fults D; Wataya T; Fryer C; Eisenstat DD; Scheineman K; Johnston D; Michaud J; Zelcer S; Hammond R; Ramsay DA; Fleming AJ; Lulla RR; Fangusaro JR; Sirachainan N; Larbcharoensub N; Hongeng S; Barakzai MA; Montpetit A; Stephens D; Grundy RG; Schüller U; Nicolaides T; Tihan T; Phillips J; Taylor MD; Rutka JT; Dirks P; Bader GD; Warmuth-Metz M; Rutkowski S; Pietsch T; Judkins AR; Jabado N; Bouffet E; Huang A
Lancet Oncol; 2015 May; 16(5):569-82. PubMed ID: 25882982
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors.
Messerli SM; Hoffman MM; Gnimpieba EZ; Bhardwaj RD
Mol Cancer Res; 2017 Aug; 15(8):973-983. PubMed ID: 28442586
[TBL] [Abstract][Full Text] [Related]
35. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.
Johann PD; Erkek S; Zapatka M; Kerl K; Buchhalter I; Hovestadt V; Jones DTW; Sturm D; Hermann C; Segura Wang M; Korshunov A; Rhyzova M; Gröbner S; Brabetz S; Chavez L; Bens S; Gröschel S; Kratochwil F; Wittmann A; Sieber L; Geörg C; Wolf S; Beck K; Oyen F; Capper D; van Sluis P; Volckmann R; Koster J; Versteeg R; von Deimling A; Milde T; Witt O; Kulozik AE; Ebinger M; Shalaby T; Grotzer M; Sumerauer D; Zamecnik J; Mora J; Jabado N; Taylor MD; Huang A; Aronica E; Bertoni A; Radlwimmer B; Pietsch T; Schüller U; Schneppenheim R; Northcott PA; Korbel JO; Siebert R; Frühwald MC; Lichter P; Eils R; Gajjar A; Hasselblatt M; Pfister SM; Kool M
Cancer Cell; 2016 Mar; 29(3):379-393. PubMed ID: 26923874
[TBL] [Abstract][Full Text] [Related]
36. Dural-based atypical teratoid/rhabdoid tumor in an adult: DNA methylation profiling as a tool for the diagnosis.
Alzoubi H; Gianno F; Giangaspero F; Bartolini D; Riccioni L; Miele E; Antonelli M
CNS Oncol; 2020 Jun; 9(2):CNS54. PubMed ID: 32602741
[TBL] [Abstract][Full Text] [Related]
37. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
39. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
Wang J; Tian Y; Chen H; Li H; Zheng S
Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor.
Suzuki M; Kondo A; Ogino I; Arai H; Tomita T; Sredni ST
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
